USANA Health Sciences, Inc. (NYSE:USNA – Get Free Report) Director Gilbert A. Fuller sold 490 shares of USANA Health Sciences stock in a transaction dated Tuesday, May 7th. The stock was sold at an average price of $44.59, for a total value of $21,849.10. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.
USANA Health Sciences Stock Up 0.3 %
NYSE USNA traded up $0.12 during trading hours on Tuesday, hitting $44.74. 61,789 shares of the company were exchanged, compared to its average volume of 81,501. The firm has a market cap of $858.91 million, a price-to-earnings ratio of 13.94, a PEG ratio of 1.38 and a beta of 0.94. The company has a 50 day moving average of $46.54 and a two-hundred day moving average of $48.15. USANA Health Sciences, Inc. has a 52-week low of $41.45 and a 52-week high of $69.60.
USANA Health Sciences (NYSE:USNA – Get Free Report) last posted its earnings results on Tuesday, February 6th. The company reported $0.87 earnings per share for the quarter, beating the consensus estimate of $0.52 by $0.35. USANA Health Sciences had a return on equity of 12.80% and a net margin of 6.88%. The business had revenue of $221.08 million during the quarter, compared to the consensus estimate of $206.70 million. On average, equities research analysts predict that USANA Health Sciences, Inc. will post 2.75 EPS for the current year.
Analyst Ratings Changes
View Our Latest Analysis on USANA Health Sciences
Institutional Inflows and Outflows
A number of hedge funds have recently added to or reduced their stakes in the stock. Quest Partners LLC purchased a new position in USANA Health Sciences in the 4th quarter valued at about $66,000. CWM LLC grew its stake in USANA Health Sciences by 49.6% in the 4th quarter. CWM LLC now owns 1,267 shares of the company’s stock worth $68,000 after acquiring an additional 420 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank raised its holdings in USANA Health Sciences by 60.6% in the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 3,376 shares of the company’s stock valued at $198,000 after acquiring an additional 1,274 shares during the last quarter. Trexquant Investment LP acquired a new stake in shares of USANA Health Sciences during the fourth quarter worth $266,000. Finally, Teacher Retirement System of Texas acquired a new position in USANA Health Sciences in the third quarter valued at $297,000. 54.25% of the stock is owned by hedge funds and other institutional investors.
USANA Health Sciences Company Profile
USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.
Featured Stories
- Five stocks we like better than USANA Health Sciences
- What Are Dividend Challengers?
- Garmin Navigates to New Highs Driven By Wearables Trend
- Find and Profitably Trade Stocks at 52-Week Lows
- Pinterest Prospers From AI Boosting Shop-Ability and Relevance
- How to Invest in the Best Canadian StocksĀ
- AbbVie Tracking for New Highs in 2024
Receive News & Ratings for USANA Health Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences and related companies with MarketBeat.com's FREE daily email newsletter.